Metabolic Syndrome in an Aging Society – Role of Oxidant-Antioxidant Imbalance and Inflammation Markers in Disentangling Atherosclerosis

References

• GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544.27733281
   PubMed Web of Science ®Google Scholar
• Salari A, Shakiba M, Mahdavi-Roshan M, et al. The association between various indices of obesity and severity of atherosclerosis in adults in the north of Iran. Medicine. 2016;95(50):e5670. doi:10.1097/MD.000000000000567027977617
   PubMed Web of Science ®Google Scholar
• Ambale-Venkatesh B, Yang X, Wu CO, et al. Cardiovascular Event prediction by machine learning: the Multi-Ethnic Study of Atherosclerosis. Circ Res. 2017;121(9):1092–1101. doi:10.1161/CIRCRESAHA.117.31131228794054
   PubMed Web of Science ®Google Scholar
• Klisić A, Kavarić N, Bjelaković B, et al. Cardiovascular risk assessed by reynolds risk score in relation to waist circumference in apparently healthy middle-aged population in Montenegro. Acta Clin Croat. 2018;57:22–30. doi:10.20471/acc.2018.57.01.0330256008
   PubMed Web of Science ®Google Scholar
• Gao X, Song J, Watase H, et al.; on behalf of CARE-II Investigators. Differences in carotid plaques between symptomatic patients with and without diabetes mellitus, A CARE-II Study. Arterioscler Thromb Vasc Biol. 2019;39(6):1234–1239. doi:10.1161/ATVBAHA.118.31209231070472
   PubMed Web of Science ®Google Scholar
• Ouchi Y, Sasaki J, Arai H, et al. Ezetimibe Lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (EWTOPIA 75): a randomized, controlled trial. Circulation. 2019;140(12):992–1003. doi:10.1161/CIRCULATIONAHA.118.03941531434507
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Nordestgaard BG. Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat. JAMA Cardiol. 2019;4(11):1131–1138. doi:10.1001/jamacardio.2019.366531577339
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology. Circulation. 2019;139(25):e1162–e1177. doi:10.1161/CIR.000000000000063830586766
   PubMed Web of Science ®Google Scholar
• Lee MMY, Sattar N, McMurray JJV, Packard CJ. Statins in the prevention and treatment of heart failure: a review of the evidence. Curr Atheroscler Rep. 2019;21(10):41. doi:10.1007/s11883-019-0800-z31350612
   PubMed Web of Science ®Google Scholar
• Liu D, Liu J, Cai Y, et al. Is the future of symptomatic intracranial atherosclerotic stenosis management promising? J Neurol Neurosurg Psychiatry. 2020;91(2):122–124. doi:10.1136/jnnp-2019-32156431919104
   PubMed Web of Science ®Google Scholar
• Nelson AJ, Peterson ED, Pagidipati NJ. Atherosclerotic cardiovascular disease and heart failure: determinants of risk and outcomes in patients with diabetes. Prog Cardiovasc Dis. 2019;62(4):306–314. doi:10.1016/j.pcad.2019.07.00131301314
   PubMed Web of Science ®Google Scholar
• Lamprea-Montealegre JA, Zelnick LR, Hall YN, et al. Prevalence of hypertension and cardiovascular risk according to blood pressure thresholds used for diagnosis. Hypertension. 2018;72(3):602–609. doi:10.1161/HYPERTENSIONAHA.118.1160930354757
   PubMed Web of Science ®Google Scholar
• Sundbøll J, Larsen AP, Veres K, et al. Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: a population-based cohort study. Thromb Res. 2019;183:124–130. doi:10.1016/j.thromres.2019.09.03431677592
   PubMed Web of Science ®Google Scholar
• Cakmak HA, Aslan S, Gul M, et al. Assessment of the relationship between a narrow fragmented QRS complex and coronary slow flow. Cardiol J. 2015;22(4):428–436. doi:10.5603/CJ.a2015.000725588536
   PubMed Web of Science ®Google Scholar
• Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713–735. doi:10.1161/CIRCRESAHA.116.30932628209797
   PubMed Web of Science ®Google Scholar
• Wu MY, Li CJ, Hou MF, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 2017;18(10):2034. doi:10.3390/ijms18102034
   PubMed Web of Science ®Google Scholar
• Wang Y, Zang QS, Liu Z, et al. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am J Physiol Cell Physiol. 2011;301(3):C695–C704. doi:10.1152/ajpcell.00322.201021653897
   PubMed Web of Science ®Google Scholar
• Cheng YC, Sheen JM, Hu WL, Hung YC. Polyphenols and oxidative stress in atherosclerosis-related ischemic heart disease and stroke. Oxid Med Cell Longev. 2017;2017:8526438. doi:10.1155/2017/852643829317985
   PubMed Web of Science ®Google Scholar
• Staerck C, Gastebois A, Vandeputte P, et al. Microbial antioxidant defense enzymes. Microb Pathog. 2017;110:56–65. doi:10.1016/j.micpath.2017.06.01528629723
   PubMed Web of Science ®Google Scholar
• Morgan MJ, Liu Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011;21(1):103–115. doi:10.1038/cr.2010.17821187859
   PubMed Web of Science ®Google Scholar
• Park K, Li Q, Evcimen ND, et al. Exogenous insulin infusion can decrease atherosclerosis in diabetic rodents by improving lipids, inflammation, and endothelial function. Arterioscler Thromb Vasc Biol. 2018;38(1):92–101. doi:10.1161/ATVBAHA.117.31029129162603
   PubMed Web of Science ®Google Scholar
• Roth S, Singh V, Tiedt S, et al. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke. Sci Transl Med. 2018;10(432):eaao1313. doi:10.1126/scitranslmed.aao131329540615
   PubMed Web of Science ®Google Scholar
• Brandsma E, Kloosterhuis NJ, Koster M, et al. A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis. Circ Res. 2019;124(1):94–100. doi:10.1161/CIRCRESAHA.118.31323430582442
   PubMed Web of Science ®Google Scholar
• Heger LA, Hortmann M, Albrecht M, et al. Inflammation in acute coronary syndrome: expression of TLR2 mRNA is increased in platelets of patients with ACS. PLoS One. 2019;14(10):e0224181. doi:10.1371/journal.pone.022418131644579
   PubMed Web of Science ®Google Scholar
• Szpak D, Grochowalski A, Chrząszcz R, et al. Tobacco smoke exposure and endothelial dysfunction in patients with advanced coronary artery disease. Pol Arch Med Wewn. 2013;123(9):474–481. doi:10.20452/pamw.188923827987
   PubMed Web of Science ®Google Scholar
• Luchetti F, Crinelli R, Cesarini E, et al. Endothelial cells, endoplasmic reticulum stress and oxysterols. Redox Biol. 2017;13:581–587. doi:10.1016/j.redox.2017.07.01428783588
   PubMed Web of Science ®Google Scholar
• Li XK, Zhang SF, Xu W, et al. Vascular endothelial injury in severe fever with thrombocytopenia syndrome caused by the novel bunyavirus. Virology. 2018;520:11–20. doi:10.1016/j.virol.2018.05.00129754008
   PubMed Web of Science ®Google Scholar
• Crowther MA. Pathogenesis of atherosclerosis. ASH Educ Prog. 2005;2005:436–441.
   Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–325. doi:10.1038/nature1014621593864
   PubMed Web of Science ®Google Scholar
• Roy A, Saqib U, Wary K, Baig MS. Macrophage neuronal nitric oxide synthase (NOS1) controls the inflammatory response and foam cell formation in atherosclerosis. Int Immunopharmacol. 2020;83:106382. doi:10.1016/j.intimp.2020.10638232193098
   PubMed Web of Science ®Google Scholar
• Chong H, Wei Z, Na M, et al. The PGC-1α/NRF1/miR-378a axis protects vascular smooth muscle cells from FFA-induced proliferation, migration and inflammation in atherosclerosis. Atherosclerosis. 2020;297:136–145. doi:10.1016/j.atherosclerosis.2020.02.00132120345
   PubMed Web of Science ®Google Scholar
• Kang C, Li JL. Role of PGC-1α signaling in skeletal muscle health and disease. Ann N Y Acad Sci. 2012;1271(1):110–117. doi:10.1111/j.1749-6632.2012.06738.x23050972
   PubMed Web of Science ®Google Scholar
• Kadlec AO, Chabowski DS, Ait-Aissa K, et al. PGC-1alpha overexpression in coronary artery disease recruits nitric oxide and hydrogen peroxide during flow mediated dilation and protects against increased intraluminal pressure. Hypertension. 2017;70:166–173. doi:10.1161/HYPERTENSIONAHA.117.0928928533333
   PubMed Web of Science ®Google Scholar
• Kadlec AO, Chabowski DS, Ait-Aissa K, et al. Role of PGC-1α in vascular regulation: implications for atherosclerosis. Arterioscler Thromb Vasc Biol. 2019;247:48–59.
   Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011;15(6):1583–1606. doi:10.1089/ars.2011.399921473702
   PubMed Web of Science ®Google Scholar
• Berg G, Barchuk M, Miksztowicz V. Behavior of metalloproteinases in adipose tissue, liver and arterial wall: an update of extracellular matrix remodeling. Cells. 2019;8(2):158. doi:10.3390/cells8020158
   Web of Science ®Google Scholar
• Sherling DH, Perumareddi P, Hennekens CH. Metabolic syndrome: clinical and policy implications of the new silent killer. J Cardiovasc Pharmacol Ther. 2017;22(4):365–367. doi:10.1177/107424841668618728587579
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.19264419805654
   PubMed Web of Science ®Google Scholar
• Caimi G, Lo Presti R, Montana M, et al. Lipid peroxidation, nitric oxide metabolites, and their ratio in a group of subjects with metabolic syndrome. Oxid Med Cell Longev. 2014;2014:824756. doi:10.1155/2014/82475624987495
   PubMed Web of Science ®Google Scholar
• Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84(21–22):705–712. doi:10.1016/j.lfs.2009.02.02619281826
   PubMed Web of Science ®Google Scholar
• Marseglia L, Manti S, D’Angelo S, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2015;16:378–400. doi:10.3390/ijms16010378
   Web of Science ®Google Scholar
• Sottero B, Gargiulo S, Russo I, et al. Postprandial dysmetabolism and oxidative stress in type 2 diabetes: pathogenetic mechanisms and therapeutic strategies. Med Res Rev. 2015;35(5):968–1031. doi:10.1002/med.2134925943420
   PubMed Web of Science ®Google Scholar
• Dzięgielewska-Gęsiak S, Płóciniczak A, Wilemska-Kucharzewska K, et al. The relationship between plasma lipids, oxidant–antioxidant status, and glycated proteins in individuals at risk for atherosclerosis. Clin Interv Aging. 2019;14:789–796. doi:10.2147/CIA.S19601631190766
   PubMed Web of Science ®Google Scholar
• Khalfa A, Tiali A, Zemour L, et al. Prevalence of metabolic syndrome and its association with lifestyle and cardiovascular biomarkers among postmenopausal women in western Algeria. Int J Gynaecol Obstet. 2017;138(2):201–206. doi:10.1002/ijgo.1220628494104
   PubMed Web of Science ®Google Scholar
• Klisic A, Kocic G, Kavaric N, et al. Nitric oxide products are not associated with metabolic syndrome. J Med Biochem. 2019;38(3):361–367. doi:10.2478/jomb-2018-003531156347
   PubMed Web of Science ®Google Scholar
• Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3(4):279–288. doi:10.4161/gmic.1962522572877
   PubMed Web of Science ®Google Scholar
• Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–546. doi:10.1038/nature1250623985870
   PubMed Web of Science ®Google Scholar
• Halmos T, Suba I. Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome. Orv Hetil. 2016;157:13–22. doi:10.1556/650.2015.3029626708682
   PubMed Web of Science ®Google Scholar
• Lazar V, Ditu LM, Pircalabioru GG, et al. Gut microbiota, host organism, and diet trialogue in diabetes and obesity. Front Nutr. 2019;6:21–26. doi:10.3389/fnut.2019.0002130931309
   PubMed Web of Science ®Google Scholar
• Schunkert H, Moebus S, Hanisch J, et al. The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS). Clin Res Cardiol. 2008;97(11):827–835. doi:10.1007/s00392-008-0694-118648725
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Facchetti R, et al. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J Hypertens. 2010;28(5):999–1006. doi:10.1097/HJH.0b013e328337a9e320308922
   PubMed Web of Science ®Google Scholar
• Adenan DM, Jaafar Z, Jayapalan JJ, Abdul Aziz A. Plasma antioxidants and oxidative stress status in obese women: correlation with cardiopulmonary response. PeerJ. 2020;8:e9230. doi:10.7717/peerj.923032477840
   PubMed Web of Science ®Google Scholar
• Frasca D, Blomberg BB, Paganelli R. Aging, obesity, and inflammatory age-related diseases. Front Immunol. 2017;8:1–10. doi:10.3389/fimmu.2017.0174528149297
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Tang X, Luo Q, Xu D, Yu B. Interaction between adipocytes and high-density lipoprotein: newinsights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019;18(1):223. doi:10.1186/s12944-019-1170-931842884
   PubMed Web of Science ®Google Scholar
• Lisko I, Tiainen K, Stenholm S, et al. Are body mass index, waist circumference and waist-to-hip ratio associated with leptin in 90-year-old people? Eur J Clin Nutr. 2013;67(4):420–422. doi:10.1038/ejcn.2013.3923443829
   PubMed Web of Science ®Google Scholar
• Bonneau GA, Pedrozo WR, Berg G. Adiponectin and waist circumference as predictors of insulin-resistance in women. Diabetes Metab Syndr. 2014;8(1):3–7. doi:10.1016/j.dsx.2013.10.00524661750
   PubMedGoogle Scholar
• Alkaabi J, Gariballa S, Sharma C, et al. Inflammatory markers and cardiovascular risks among overweight-obese emirati women. BMC Res Notes. 2016;9(1):355. doi:10.1186/s13104-016-2160-x27440160
   PubMedGoogle Scholar
• Holewijn S, den Heijer M, van Tits LJ, Swinkels DW, Stalenhoef AF, de Graaf J. Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population. J Intern Med. 2010;267(6):588–598. doi:10.1111/j.1365-2796.2009.02192.x20210840
   PubMed Web of Science ®Google Scholar
• Lee-Chang C, Bodogai M, Moritoh K, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124(9):1450–1459. doi:10.1182/blood-2014-03-56394025037628
   PubMed Web of Science ®Google Scholar
• Agarwal N, Chitrika A, Bhattacharjee J, Jain SK. Correlation of tumor necrosis factor-α and interleukin-6 with anthropometric indices of obesity and parameters of insulin resistance in healthy north Indian population. JIACM. 2011;12(3):196–204.
   Google Scholar
• Nieto-Vasquez I, Vern{ndez-Veledo S, Kr{mer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114(3):183–194. doi:10.1080/1381345080218104718629684
   PubMedGoogle Scholar
• Popko K, Gorska E, Stelmaszczyk-Emmel A, et al. Proinfl ammatory cytokines IL-6 and TNF-α and the development of infl ammation in obese subjects. Eur J Med Res. 2010;15:120–122. doi:10.1186/2047-783X-15-S2-12021147638
   PubMed Web of Science ®Google Scholar
• Efremov L, Lacruz ME, Tiller D, et al. Metabolically healthy, but obese individuals and associations with echocardiographic parameters and inflammatory biomarkers: results from the CARLA Study. Diabetes Metab Syndr Obes. 2020;13:2653–2665. doi:10.2147/DMSO.S26372732821138
   PubMed Web of Science ®Google Scholar
• Adachi K, Sugiyama T, Yamaguchi Y, et al. Gut microbiota disorders cause type 2 diabetes mellitus and homeostatic disturbances in gut-related metabolism in Japanese subjects. J Clin Biochem Nutr. 2019;64:231–238. doi:10.3164/jcbn.18-10131138957
   PubMed Web of Science ®Google Scholar
• Yadav D, Mishra M, Joseph AZ, et al. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria. Obes Res Clin Pract. 2015;9(2):158–167. doi:10.1016/j.orcp.2014.03.00425890429
   PubMed Web of Science ®Google Scholar
• Karaouzene N, Merzouk H, Aribi M, et al. Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men. Nutr Metab Cardiovasc Dis. 2011;21(10):792–799. doi:10.1016/j.numecd.2010.02.00720554180
   PubMed Web of Science ®Google Scholar
• Schwingshackl L, Hoffmann G. Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis. J Acad Nutr Diet. 2013;113(12):1640–1661. doi:10.1016/j.jand.2013.07.01024139973
   PubMed Web of Science ®Google Scholar
• Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr Atheroscler Rep. 2016;18(12):82. doi:10.1007/s11883-016-0632-z27822682
   PubMed Web of Science ®Google Scholar
• Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S. Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis. 2008;200(2):389–395. doi:10.1016/j.atherosclerosis.2007.12.02018258237
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Ceponiene I, Samargandy S, et al. HDL (High-Density Lipoprotein) metrics and atherosclerotic risk in women. Arterioscler Thromb Vasc Biol. 2018;38(9):2236–2244. doi:10.1161/ATVBAHA.118.31101730026268
   PubMed Web of Science ®Google Scholar
• Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia. 2000;43:148–155. doi:10.1007/s00125005002310753035
   PubMed Web of Science ®Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005;54(11):3252–3257. doi:10.2337/diabetes.54.11.325216249452
   PubMed Web of Science ®Google Scholar
• Millan J, Pinto X, Munoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–765.19774217
   PubMedGoogle Scholar
• Dobiasova M. AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice [AIP--aterogenní index plazmy jako významný prediktor kardiovaskularního rizika: od výzkumu do praxe]. Vnitr Lek. 2006;52(1):64–71.16526201
   PubMedGoogle Scholar
• Zhu XW, Deng FY, Lei SF. Meta-analysis of atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9(1):60–67. doi:10.1016/j.pcd.2014.03.00724810146
   PubMed Web of Science ®Google Scholar
• Polonskaya YV, Shramko VS, Morozov SV, Chernyak EI, Chernyavsky AM, Ragino YI. Balance of fatty acids and their correlations with parameters of lipid metabolism and markers of inflammation in men with coronary atherosclerosis. Bull Exp Biol Med. 2017;164(1):33–35. doi:10.1007/s10517-017-3920-x29119389
   PubMed Web of Science ®Google Scholar
• Zheng JS, Sharp SJ, Imamura F, et al. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. BMC Med. 2017;15(1):203. doi:10.1186/s12916-017-0968-429145892
   PubMed Web of Science ®Google Scholar
• Hadj Ahmed S, Kharroubi W, Kaoubaa N, et al. Correlation of trans fatty acids with the severity of coronary artery disease lesions. Lipids Health Dis. 2018;17(1):52. doi:10.1186/s12944-018-0699-329544473
   PubMed Web of Science ®Google Scholar
• Decharatchakul N, Settasatian C, Settasatian N, et al. Association of genetic polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with hypertriglyceridemia and low HDL-C level in subjects with high risk of coronary artery disease. PeerJ. 2019;7:e7407. doi:10.7717/peerj.740731396447
   PubMed Web of Science ®Google Scholar
• Dzięgielewska-Gęsiak S, Bielawska L, Zowczak-Drabarczyk M, et al. The impact of high-density lipoprotein on oxidant-antioxidant balance in healthy elderly people. Pol Arch Med Wewn. 2016;126(10):731–738. doi:10.20452/pamw.355927650303
   PubMed Web of Science ®Google Scholar
• Singh K, Singh R, Chandra S, Tyagi S. Paraoxonase-1 is a better indicator than HDL of atherosclerosis - a pilot study in North Indian population. Diabetes Metab Syndr. 2018;12(3):275–278. doi:10.1016/j.dsx.2017.12.00629254890
   PubMed Web of Science ®Google Scholar
• Hao W, Friedman A. The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. PLoS One. 2014;9(3):e90497. doi:10.1371/journal.pone.009049724621857
   PubMed Web of Science ®Google Scholar
• Formanowicz D, Krawczyk JB, Perek B, Formanowicz P. A control-theoretic model of atherosclerosis. Int J Mol Sci. 2019;20(3):785. doi:10.3390/ijms20030785
   Web of Science ®Google Scholar
• Paun A, Danska JS. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr Diabetes. 2016;17:469–476. doi:10.1111/pedi.1242427484959
   PubMed Web of Science ®Google Scholar
• Ruotsalainen E, Salmenniemi U, Vauhkonen I, et al. Changes in Inflammatory cytokines are related to impaired glucose tolerance in Offspring of type 2 diabetic subjects. Diabetes Care. 2006;29(12):2714–2720. doi:10.2337/dc06-014717130210
   PubMed Web of Science ®Google Scholar
• Woo CY, Jang JE, Lee SE, Koh EH, Lee KU. Mitochondrial dysfunction in adipocytes as a primary cause of adipose tissue inflammation. Diabetes Metab J. 2019;43:247–256. doi:10.4093/dmj.2018.022130968618
   PubMed Web of Science ®Google Scholar
• Saukkonen T, Mutt SJ, Jokelainen J, et al. Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease. Sci Rep. 2018;8(1):12816. doi:10.1038/s41598-018-31144-830143687
   PubMed Web of Science ®Google Scholar
• Rizza S, Cardellini M, Martelli E, et al. Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation. Atherosclerosis. 2010;212(1):316–320. doi:10.1016/j.atherosclerosis.2010.05.01720554281
   PubMed Web of Science ®Google Scholar
• Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z. The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol. 2012;49(1):3–7. doi:10.1007/s00592-010-0198-020495833
   PubMed Web of Science ®Google Scholar
• Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol. 2010;21:312–318. doi:10.1097/MOL.0b013e32833bcdc120581677
   PubMed Web of Science ®Google Scholar
• Dullaart RP, Annema W, Tio RA, Tietge UJ. The HDL anti-infammatory function is impaired in myocardial infarction and may predict new cardiac events independent of HDL cholesterol. Clin Chim Acta. 2014;433:34–38. doi:10.1016/j.cca.2014.02.02624613518
   PubMed Web of Science ®Google Scholar
• Ebtehaj S, Gruppen EG, Parvizi M, Tietge UJF, Dullaart RPF. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation. Cardiovasc Diabetol. 2017;16(1):132. doi:10.1186/s12933-017-0613-829025405
   PubMed Web of Science ®Google Scholar
• Hernaez A, Soria-Florido MT, Schröder H, et al. Role of HDL function and LDL atherogenicity on cardiovascular risk: a comprehensive examination. PLoS One. 2019;14(6):e0218533. doi:10.1371/journal.pone.021853331246976
   PubMed Web of Science ®Google Scholar
• Dzięgielewska-Gęsiak S, Wysocka E, Michalak S, Nowakowska-Zajdel E, Kokot T, Muc-Wierzgoń M. Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics. Oxid Med Cell Longev. 2014;2014:987303. doi:10.1155/2014/98730324891926
   PubMed Web of Science ®Google Scholar
• Kozakova M, Morizzo C, Goncalves I, Natali A, Nilsson J, Palombo C. Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation. Cardiovasc Diabetol. 2019;18(1):61. doi:10.1186/s12933-019-0865-631077210
   PubMed Web of Science ®Google Scholar
• Manabe S, Okura T, Watanabe S, Higaki J. Association between carotid haemodynamics and inflammation in patients with essential hypertension. J Hum Hypertens. 2005;19(10):787–791. doi:10.1038/sj.jhh.100189815988541
   PubMed Web of Science ®Google Scholar
• Caimi G, Mulè G, Hopps E, Carollo C, Lo Presti R. Nitric oxide metabolites and oxidative stress in mild essential hypertension. Clin Hemorheol Microcirc. 2010;46(4):321–325. doi:10.3233/CH-2010-136021187581
   PubMed Web of Science ®Google Scholar
• Saraswathi R, Sankar D, Ali A, et al. A pilot assessment of oxidative stress byproducts and antioxidant activities among Indian patients with various stages of hypertension. Clin Exp Hypertens. 2011;33(7):437–443. doi:10.3109/10641963.2010.54925921627488
   PubMed Web of Science ®Google Scholar
• Cao J, Wang HY. Association between total antioxidant status and atherosclerosis in elderly patients with essential hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41(10):857–861.24377892
   PubMedGoogle Scholar
• Kaypaklı O, Gür M, Harbalıoğlu H, Şeker T, Selek Ş. High morning blood pressure surge is associated with oxidative stress and paraoxonase 1 activity in newly diagnosed hypertensive patients. Clin Exp Hypertens. 2016;38(8):680–685. doi:10.1080/10641963.2016.120060227936340
   PubMed Web of Science ®Google Scholar
• Gómez-Marcos MA, Blazquez-Medela AM, Gamella-Pozuelo L, Recio-Rodriguez JI, García-Ortiz L, Martínez-Salgado C. Serum superoxide dismutase is associated with vascular structure and function in hypertensive and diabetic patients. Oxid Med Cell Longev. 2016;2016:9124676. doi:10.1155/2016/912467626635913
   PubMed Web of Science ®Google Scholar
• Kou H, Deng J, Gao D, et al. Relationship among adiponectin, insulin resistance and atherosclerosis in non-diabetic hypertensive patients and healthy adults. Clin Exp Hypertens. 2018;40(7):656–663. doi:10.1080/10641963.2018.142541429336612
   PubMed Web of Science ®Google Scholar
• David S, Kümpers P, Lukasz A, Kielstein JT, Haller H, Fliser D. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin. J Hypertens. 2009;27(8):1641–1647. doi:10.1097/HJH.0b013e32832be57519390459
   PubMed Web of Science ®Google Scholar
• Lakoski SG, Cushman M, Siscovick DS, et al. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2011;25(2):73–79. doi:10.1038/jhh.2010.9120944659
   PubMed Web of Science ®Google Scholar
• Jayedi A, Rahimi K, Bautista LE, Nazarzadeh M, Zargar MS, Shab-Bidar S. Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies. Heart. 2019;105(9):686–692. doi:10.1136/heartjnl-2018-31421630700522
   PubMed Web of Science ®Google Scholar
• Takagi T, Naito Y, Kashiwagi S, et al. Changes in the gut microbiota are associated with hypertension, hyperlipidemia, and type 2 diabetes mellitus in Japanese subjects. Nutrients. 2020;12(10):2996–3004. doi:10.3390/nu12102996
   PubMed Web of Science ®Google Scholar
• Dziechciaż M, Filip R. Biological psychological and social determinants of old age: bio-psycho-social aspects of human aging. Ann Agric Environ Med. 2014;21(4):835–838. doi:10.5604/12321966.112994325528930
   PubMed Web of Science ®Google Scholar
• Harman D. Free radicals in aging. Mol Cell Biochem. 1988;84(2):155–161. doi:10.1007/BF04210503068521
   PubMed Web of Science ®Google Scholar
• Camandola S, Mattson MP. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 2017;36(11):1474–1492. doi:10.15252/embj.20169581028438892
   PubMed Web of Science ®Google Scholar
• Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747–762. doi:10.1016/j.jacc.2013.09.07024291279
   PubMed Web of Science ®Google Scholar
• Malczyk E, Dzięgielewska-Gęsiak S, Fatyga E, Ziółko E, Kokot T, Muc-Wierzgoń M. Body composition in healthy older persons: role of the ratio of extracellular/total body water. J Biol Regul Homeost Agents. 2016;30(3):767–772.27655495
   PubMed Web of Science ®Google Scholar
• Potes Y, de Luxan-delgado B, Rodriguez-Gonzalez S, et al. Overweight in elderly people induces impaired autophagy in skeletal muscle. Free Radic Biol Med. 2017;110:31–41. doi:10.1016/j.freeradbiomed.2017.05.01828549989
   PubMed Web of Science ®Google Scholar
• Lee HY, Zeeshan HMA, Kim HR, et al. Nox4 regulates the eNOS uncoupling process in aging endothelial cells. Free Radic Biol Med. 2017;113:26–35. doi:10.1016/j.freeradbiomed.2017.09.01028916474
   PubMed Web of Science ®Google Scholar
• Gates PE, Strain WD, Shore AC. Human endothelial function and microvascular ageing. Exp Physiol. 2009;94(3):311–316. doi:10.1113/expphysiol.2008.04334919042980
   PubMed Web of Science ®Google Scholar
• Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110(10):1364–1390. doi:10.1161/CIRCRESAHA.111.24397222581922
   PubMed Web of Science ®Google Scholar
• Judkins CP, Diep H, Broughton BR, et al. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE−/− mice. Am J Physiol Heart Circ Physiol. 2010;298:H24–H32. doi:10.1152/ajpheart.00799.200919837950
   PubMed Web of Science ®Google Scholar
• Silva JF, Correa IC, Diniz TF, et al. Obesity, inflammation, and exercise training: relative contribution of iNOS and eNOS in the modulation of vascular function in the mouse aorta. Front Physiol. 2016;7(386):1–13. doi:10.3389/fphys.2016.0038626858649
   PubMed Web of Science ®Google Scholar
• Xiong S, Patrushev N, Forouzandeh F, et al. PGC-1α modulates telomere function and DNA damage in protecting against aging-related chronic diseases. Cell Rep. 2015;12(9):1391–1399. doi:10.1016/j.celrep.2015.07.04726299964
   PubMed Web of Science ®Google Scholar
• Salazar G, Cullen A, Huang J, et al. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence. Autophagy. 2020;16(6):1092–1110. doi:10.1080/15548627.2019.165961231441382
   PubMed Web of Science ®Google Scholar
• Varghese JF, Patel R, Yadav UCS. Novel insights in the metabolic syndrome-induced oxidative stress and inflammation-mediated atherosclerosis. Curr Cardiol Rev. 2018;14:4–14. doi:10.2174/1573403X1366617100911225028990536
   PubMed Web of Science ®Google Scholar
• Dzięgielewska-Gęsiak S, Stołtny D, Brożek A, Muc-Wierzgoń M, Wysocka E. Are insulin-resistance and oxidative stress cause or consequence of aging. Exp Biol Med (Maywood). 2020;245(14):1260–1267. doi:10.1177/153537022092962132469639
   PubMed Web of Science ®Google Scholar
• Yadav R, Yadav RK, Khadgawat R, Pandey RM. Comparative efficacy of a 12 week yoga-based lifestyle intervention and dietary intervention on adipokines, inflammation, and oxidative stress in adults with metabolic syndrome: a randomized controlled trial. Transl Behav Med. 2019;9(4):594–604. doi:10.1093/tbm/iby06030020512
   PubMed Web of Science ®Google Scholar
• Beydoun MA, Fanelli-Kuczmarski MT, Beydoun HA, et al. Dairy product consumption and its association with metabolic disturbance in a prospective study of urban adults. Br J Nutr. 2018;119(6):706–719. doi:10.1017/S000711451800002829553032
   PubMed Web of Science ®Google Scholar
• Guasch-Ferré M, Babio N, Martínez-Gonz{lez MA, et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Am J Clin Nutr. 2015;102(6):1563–1573. doi:10.3945/ajcn.115.11604626561617
   PubMed Web of Science ®Google Scholar
• Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study. BMC Complement Altern Med. 2019;19(1):97. doi:10.1186/s12906-019-2509-531060549
   PubMed Web of Science ®Google Scholar
• Song J, Huang Y, Zheng W, et al. Resveratrol reduces intracellular reactive oxygen species levels by inducing autophagy through the AMPK-mTOR pathway. Front Med. 2018;12(6):697–706. doi:10.1007/s11684-018-0655-730421395
   PubMed Web of Science ®Google Scholar
• Bagul PK, Deepthi N, Sultana R, Banerjee SK. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem. 2015;26:1298–1307. doi:10.1016/j.jnutbio.2015.06.00626298192
   PubMed Web of Science ®Google Scholar
• Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14:612–622. doi:10.1016/j.cmet.2011.10.00222055504
   PubMed Web of Science ®Google Scholar
• Fontana L, Villareal DT, Das SK, et al. Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial. Aging Cell. 2016;15:22–27. doi:10.1111/acel.1240026443692
   PubMed Web of Science ®Google Scholar
• Villareal DT, Aguirre L, Gurney AB, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376(20):1943–1955. doi:10.1056/NEJMoa161633828514618
   PubMed Web of Science ®Google Scholar
• Illan-Gómez F, Gonzalvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22(6):950–955. doi:10.1007/s11695-012-0643-y22527592
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhu X, Chen K, et al. Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging. 2019;11:2217–2240. doi:10.18632/aging.10191030988232
   PubMedGoogle Scholar
• Solomon TP, Sistrun SN, Krishnan RK, et al. Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. J Appl Physiol. 2008;104(5):1313–1319. doi:10.1152/japplphysiol.00890.200718323464
   PubMed Web of Science ®Google Scholar
• Rom O, Volkova N, Jeries H, Grajeda-Iglesias C, Aviram M. Exogenous (Pomegranate juice) or Endogenous (Paraoxonase1) antioxidants decrease triacylglycerol accumulation in mouse cardiovascular disease-related tissues. Lipids. 2018;53(11–12):1031–1041. doi:10.1002/lipd.1211230560569
   PubMed Web of Science ®Google Scholar
• Wielkoszyński T, Zalejska-Fiolka J, Strzelczyk JK, et al. Oxysterols increase inflammation, lipid marker levels and reflect accelerated endothelial dysfunction in experimental animals. Mediators Inflamm. 2018;ID 2784701. doi:10.1155/2018/2784701
   Web of Science ®Google Scholar
• Verhoeven V, Van der Auwera A, Van Gaal L, et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015;15:52. doi:10.1186/s12906-015-0576-925879228
   PubMed Web of Science ®Google Scholar
• Zhu X, Yang J, Zhu W, et al. Combination of berberine with resveratrol improves the lipid-lowering efficacy. Int J Mol Sci. 2018;19(12):3903. doi:10.3390/ijms19123903
   PubMed Web of Science ®Google Scholar
• Gabriel B, Ratkevicius A, Gray P, Frenneaux MP, Gray SR. High-intensity exercise attenuates postprandial lipaemia and markers of oxidative stress. Clin Sci. 2012;123(5):313–321. doi:10.1042/CS20110600
   Web of Science ®Google Scholar
• Sawada T, Tsubata H, Hashimoto N, et al. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial. Cardiovasc Diabetol. 2016;15(1):121. doi:10.1186/s12933-016-0437-y27565734
   PubMed Web of Science ®Google Scholar
• Kim H, Simbo SY, Fang C, et al. Açaí (Euterpe oleracea Mart.) beverage consumption improves biomarkers for inflammation but not glucose- or lipid-metabolism in individuals with metabolic syndrome in a randomized, double-blinded, placebo-controlled clinical trial. Food Funct. 2018;9(6):3097–3103. doi:10.1039/c8fo00595h29850709
   PubMed Web of Science ®Google Scholar
• Farabi SS, Carley DW, Smith D, Quinn L. Impact of exercise on diurnal and nocturnal markers of glycaemic variability and oxidative stress in obese individuals with type 2 diabetes or impaired glucose tolerance. Diab Vasc Dis Res. 2015;12(5):381–385. doi:10.1177/147916411557900325994591
   PubMed Web of Science ®Google Scholar
• Johnson SA, Figueroa A, Navaei N, et al. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015;115(3):369–377. doi:10.1016/j.jand.2014.11.00125578927
   PubMed Web of Science ®Google Scholar
• Choy KW, Lau YS, Murugan D, Mustafa MR, Bader M. Chronic treatment with paeonol improves endothelial function in mice through inhibition of endoplasmic reticulum stress-mediated oxidative stress. PLoS One. 2017;12(5):e0178365. doi:10.1371/journal.pone.017836528562691
   PubMed Web of Science ®Google Scholar
• Barili A, Corralo VDS, Cardoso AM, et al. Acute responses of hemodynamic and oxidative stress parameters to aerobic exercise with blood flow restriction in hypertensive elderly women. Mol Biol Rep. 2018;45(5):1099–1109. doi:10.1007/s11033-018-4261-130030775
   PubMed Web of Science ®Google Scholar
• Dolati S, Namiranian K, Amerian R, et al. The effect of curcumin supplementation and aerobic training on anthropometric indices, serum lipid profiles, C-reactive protein and insulin resistance in overweight women: a randomized, double-blind, placebo-controlled trial. J Obes Metab Syndr. 2020;29(1):47–57. doi:10.7570/jomes1905532145720
   PubMed Web of Science ®Google Scholar
• Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016;167:257–280.26207884
   PubMed Web of Science ®Google Scholar
• Kelany ME, Hakami TM, Omar AH. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Can J Physiol Pharmacol. 2017;95:140–150. doi:10.1139/cjpp-2016-015227901349
   PubMed Web of Science ®Google Scholar
• Dogaru G, Bulboaca AE, Gheban D, et al. Effect of liposomal curcumin on acetaminophen hepatotoxicity by down-regulation of oxidative stress and matrix metalloproteinases. In Vivo. 2020;34(2):569–582. doi:10.21873/invivo.1180932111755
   PubMed Web of Science ®Google Scholar
• Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Zachariah B. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male wistar rats: potential role of serine kinases. Chem Biol Interact. 2016;244:187–194. doi:10.1016/j.cbi.2015.12.01226713546
   PubMed Web of Science ®Google Scholar